American Bitcoin Corp (ABTC) vs Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)

A side-by-side comparison of American Bitcoin Corp and Drugs Made In America Acquisition II Corp. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
American Bitcoin Corp logo
ABTC
American Bitcoin Corp
$635M
$8.71Financial ServicesDelayed quote: Oct 5, 2026, 4:00 PM EDT
Drugs Made In America Acquisition II Corp. Ordinary Shares logo
DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
$649M
$10.19Financial ServicesDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ABTC vs DMII

growth of $100 · dividends reinvested · last 1y
ABTC -73.5% (-73.5%/yr)DMII +3.1% (+3.1%/yr)DMII compounded faster over this window
20406080100Start $1002026$27$103
ABTC DMII

ABTC vs DMII: by the numbers

  • •DMII is the larger company ($649M vs $635M market cap).
  • •Both run net losses; DMII's is the smaller (0.00% vs -71.75% net margin).

Metrics side by side

Valuation

MetricABTCDMII
P/E ratioN/A34.78
P/S ratio2.34N/A
P/B ratio0.941.31

Profitability

MetricABTCDMII
Gross margin47.06%0.00%
Operating margin-123.13%0.00%
Net margin-71.75%0.00%
ROE-29.00%2.62%
ROICN/A-0.28%

Growth (annualized)

MetricABTCDMII
Revenue CAGR (5Y)74.61%N/A
Total return CAGR (5Y)-84.01%N/A

Go deeper

Full ABTC analysisFull DMII analysisInteractive comparison tool

Dig into the metrics

Drugs Made In America Acquisition II Corp. Ordinary Shares P/E ratioAmerican Bitcoin ROEDrugs Made In America Acquisition II Corp. Ordinary Shares ROEAmerican Bitcoin operating marginDrugs Made In America Acquisition II Corp. Ordinary Shares operating marginAmerican Bitcoin revenue growthDrugs Made In America Acquisition II Corp. Ordinary Shares revenue growthDrugs Made In America Acquisition II Corp. Ordinary Shares free cash flow

American Bitcoin & Drugs Made In America Acquisition II Corp. Ordinary Shares appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.